close hamburger search alert

back to Health & Wellness

New Drug Fights Cancer in Dogs

powered by healthline

Average Ratings

Palladia approved to treat dangerous skin tumors

WEDNESDAY, June 3 (HealthDay News) -- Palladia (toceranib phosphate) is the first drug to be approved by the U.S. Food and Drug Administration specifically to treat cancer in dogs, the agency said in a news release Wednesday.

The drug has been sanctioned to treat canine cutaneous mast cell tumors, which account for about one in five cases of skin tumors in dogs.

While these tumors may appear small, they can be life-threatening if not treated and removed, the FDA said. Palladia, among a class of drugs called tyrosine kinase inhibitors, kills tumor cells and cuts off the tumors' blood supply.

The drug's side effects may include diarrhea, loss of appetite, weight loss and bloody stools.

Palladia is produced by New York City-based Pfizer Animal Health Inc.

More information

The FDA has more about this approval.


-- Scott Roberts
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Article from
Top of page
General Drug Tools
General Drug Tools
view all
Health Management
Programs
Health Management Programs
view all
Tools for
Healthy Living
Tools for Healthy Living
view all